MDM2
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
MDM2
Jun 2, 2024, 12:11 |
Blog
New clinical data being presented at the ASCO from our ongoing KT-253 Phase 1 oncology trial - Kymera Therapeutics
Pearl Freier, Founder of Cambridge BioPartners, shared a post by Kymera Therapeutics on X/Twitter: "…
May 17, 2024, 04:29 |
Insight
Rasoul Pourebrahim: New potential targets for preventing AML with p53 mutations
Rasoul Pourebrahim, Assistant Professor at MD Anderson Cancer Centre, shared on LinkedIn: "Our paper was…
May 12, 2024, 06:02 |
Insight
Rasoul Pourebrahim: Our latest publication on studying mutant p53-driven Acute Myeloid Leukemia
Rasoul Pourebrahim, Assistant Professor at MD Anderson, made the following post on LinkedIn: "Our paper…
Mar 26, 2024, 00:22 |
Opinion
Wafik S. El-Deiry: WIN Consortium in cancer personalized medicine MTB had well over 30 participants
Wafik S. El-Deiry shared on LinkedIn: "Today’s WIN Consortium in cancer personalized medicine MTB had well…
All:
4
Posts:
1 - 10
Monica Bertagnolli: Molecular Portrait of Key Driver of pancreatic cancer
We need to hurry up, because cancer and patients cannot wait!
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
Facebook
RSS Feed
Twitter
Linkedin
Youtube